UK & USA NEWS

Sarepta stock falls on FDA gene therapy Elevidys comment

Sagar3 months ago08 mins

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The…

FDA to consider drug affordability when speeding up approvals: Makary

Sagar3 months ago06 mins

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday. The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are…

How a Dodgers-Brewers NLCS defines MLB’s labor battle

Venezuela is collapsing — and don't look now, but so is Cuba

Access Denied

Penn State fires head coach James Franklin after 12 seasons

Greene's deepening split with GOP leaves Republicans exasperated

Becca Crane In ‘Vampires Suck’ ‘Memba Her?!

Marty Makary

Sarepta stock falls on FDA gene therapy Elevidys comment